Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 21


Erratum to: Immune monitoring technology primer.

Dobbin KK.

J Immunother Cancer. 2015 Nov 17;3:56. eCollection 2015.


Immune monitoring technology primer.

Dobbin KK.

J Immunother Cancer. 2015 Oct 20;3:40. doi: 10.1186/s40425-015-0086-9. eCollection 2015.


Canine spontaneous head and neck squamous cell carcinomas represent their human counterparts at the molecular level.

Liu D, Xiong H, Ellis AE, Northrup NC, Dobbin KK, Shin DM, Zhao S.

PLoS Genet. 2015 Jun 1;11(6):e1005277. doi: 10.1371/journal.pgen.1005277. eCollection 2015 Jun.


Comparison of confidence interval methods for an intra-class correlation coefficient (ICC).

Ionan AC, Polley MY, McShane LM, Dobbin KK.

BMC Med Res Methodol. 2014 Nov 22;14:121. doi: 10.1186/1471-2288-14-121.


Covariance adjustment for batch effect in gene expression data.

Lee JA, Dobbin KK, Ahn J.

Stat Med. 2014 Jul 10;33(15):2681-95. doi: 10.1002/sim.6157. Epub 2014 Mar 28.


Statistical design and evaluation of biomarker studies.

Dobbin KK.

Methods Mol Biol. 2014;1102:667-77. doi: 10.1007/978-1-62703-727-3_36. Review.


Health and personal resources in older patients with cancer undergoing chemotherapy.

Robb C, Lee A, Jacobsen P, Dobbin KK, Extermann M.

J Geriatr Oncol. 2013 Apr;4(2):166-73. doi: 10.1016/j.jgo.2012.12.002. Epub 2013 Jan 8.


Sample size requirements for training high-dimensional risk predictors.

Dobbin KK, Song X.

Biostatistics. 2013 Sep;14(4):639-52. doi: 10.1093/biostatistics/kxt022. Epub 2013 Jul 19.


Lower confidence bounds for prediction accuracy in high dimensions via AROHIL Monte Carlo.

Dobbin KK, Cooke S.

Bioinformatics. 2011 Nov 15;27(22):3129-34. doi: 10.1093/bioinformatics/btr542. Epub 2011 Sep 28.


Optimally splitting cases for training and testing high dimensional classifiers.

Dobbin KK, Simon RM.

BMC Med Genomics. 2011 Apr 8;4:31. doi: 10.1186/1755-8794-4-31.


Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome.

Harvey RC, Mullighan CG, Wang X, Dobbin KK, Davidson GS, Bedrick EJ, Chen IM, Atlas SR, Kang H, Ar K, Wilson CS, Wharton W, Murphy M, Devidas M, Carroll AJ, Borowitz MJ, Bowman WP, Downing JR, Relling M, Yang J, Bhojwani D, Carroll WL, Camitta B, Reaman GH, Smith M, Hunger SP, Willman CL.

Blood. 2010 Dec 2;116(23):4874-84. doi: 10.1182/blood-2009-08-239681. Epub 2010 Aug 10.


Guidelines for the development and incorporation of biomarker studies in early clinical trials of novel agents.

Dancey JE, Dobbin KK, Groshen S, Jessup JM, Hruszkewycz AH, Koehler M, Parchment R, Ratain MJ, Shankar LK, Stadler WM, True LD, Gravell A, Grever MR; Biomarkers Task Force of the NCI Investigational Drug Steering Committee.

Clin Cancer Res. 2010 Mar 15;16(6):1745-55. doi: 10.1158/1078-0432.CCR-09-2167. Epub 2010 Mar 9.


Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia.

Harvey RC, Mullighan CG, Chen IM, Wharton W, Mikhail FM, Carroll AJ, Kang H, Liu W, Dobbin KK, Smith MA, Carroll WL, Devidas M, Bowman WP, Camitta BM, Reaman GH, Hunger SP, Downing JR, Willman CL.

Blood. 2010 Jul 1;115(26):5312-21. doi: 10.1182/blood-2009-09-245944. Epub 2010 Feb 4.


A method for constructing a confidence bound for the actual error rate of a prediction rule in high dimensions.

Dobbin KK.

Biostatistics. 2009 Apr;10(2):282-96. doi: 10.1093/biostatistics/kxn035. Epub 2008 Nov 27.


Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study.

Director's Challenge Consortium for the Molecular Classification of Lung Adenocarcinoma, Shedden K, Taylor JM, Enkemann SA, Tsao MS, Yeatman TJ, Gerald WL, Eschrich S, Jurisica I, Giordano TJ, Misek DE, Chang AC, Zhu CQ, Strumpf D, Hanash S, Shepherd FA, Ding K, Seymour L, Naoki K, Pennell N, Weir B, Verhaak R, Ladd-Acosta C, Golub T, Gruidl M, Sharma A, Szoke J, Zakowski M, Rusch V, Kris M, Viale A, Motoi N, Travis W, Conley B, Seshan VE, Meyerson M, Kuick R, Dobbin KK, Lively T, Jacobson JW, Beer DG.

Nat Med. 2008 Aug;14(8):822-7. doi: 10.1038/nm.1790. Epub 2008 Jul 20.


How large a training set is needed to develop a classifier for microarray data?

Dobbin KK, Zhao Y, Simon RM.

Clin Cancer Res. 2008 Jan 1;14(1):108-14. doi: 10.1158/1078-0432.CCR-07-0443.


Five-gene signature in non-small-cell lung cancer.

Dobbin KK.

N Engl J Med. 2007 Apr 12;356(15):1582; author reply 1583. No abstract available.


Sample size planning for developing classifiers using high-dimensional DNA microarray data.

Dobbin KK, Simon RM.

Biostatistics. 2007 Jan;8(1):101-17. Epub 2006 Apr 13.


Comment on 'Evaluation of the gene-specific dye bias in cDNA microarray experiments'.

Dobbin KK, Shih JH, Simon RM.

Bioinformatics. 2005 Jun 15;21(12):2803-4. Epub 2005 Apr 7. No abstract available.


Characterizing dye bias in microarray experiments.

Dobbin KK, Kawasaki ES, Petersen DW, Simon RM.

Bioinformatics. 2005 May 15;21(10):2430-7. Epub 2005 Mar 17.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk